On the use of substandard medicines in hematology: An emerging concern in the Middle East and North Africa region

Mervat Mattar 1Collaborators of the NEtwork for Drug Quality and Safety (NEDQAS)

Collaborators

Collaborators of the NEtwork for Drug Quality and Safety (NEDQAS)Alaa F Alwan 2Houria Boukhelal 3Zoubir Chouffai 4Fadi Farhat 5Mahmoud Hadipour 6Emad Hamada 7Mohamed Kadhim Jaffar 8Mehran Karimi 9Fawaz Al-Kasim 10Hayder H Al-Momen 11Ahmad M Tarawah 12Atholl Johnston 13Khaled M Musallam 14

Affiliations

1Clinical Hematology Unit, Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt. Electronic address: mermattar770@gmail.com.

2National Center of Hematology and University College of Medicine, Baghdad, Iraq.

3University Hospital CHU Mustapha, Algiers, Algeria.

4Pediatric Oncology & Hematology Center, Casablanca, Morocco.

5Hammoud Hospital, Sidon, Lebanon.

6Iranian Thalassemia Society, Iran.

7Cairo University, Cairo, Egypt.

8Iraqi CML Patient Organization, Iraq.

9Hematology Research Center, Nemazee Hospital, Shiraz, Iran.

10King Saud Medical City, Riyadh, Saudi Arabia.

11Al-Kindy College of Medicine, Baghdad University, Baghdad, Iraq.

12Madinah Blood Disorders Center, King Abdullah Medical City, Madinah, Saudi Arabia.

13Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

14International Network of Hematology, London, UK.

PMID: 29239738

DOI: 10.1016/j.ejim.2017.08.003

No abstract available

Keywords: Copy drugs; Hematology; Middle east; Substandard medicines.